Skip to main content
Top
Published in: BMC Psychiatry 1/2020

Open Access 01-12-2020 | Multiple Sclerosis | Research article

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study

Authors: Saba Karimi, Bahare Andayeshgar, Alireza Khatony

Published in: BMC Psychiatry | Issue 1/2020

Login to get access

Abstract

Background

Multiple sclerosis (MS) is a chronic disease that decreases the physical ability and affects the mental health of the patients. This descriptive-analytical study investigated the prevalence of depression, anxiety and stress in MS patients.

Methods

A total of 87 MS patients were recruited in this study through simple random sampling method using a random number table. Data were collected by Depression, Anxiety, and Stress Scale-21 (DASS-21) and analyzed by descriptive and analytical statistics.

Results

The mean age of the patients was 35.5 ± 9.2 years. Of them, 41 (47.1%) had moderate depression, 34 (39.1%) had moderate anxiety, and 39 (44.8%) had moderate stress. There was a significant relationship between depression and job, education, and economic status of the participants. There was also a significant association between the participants’ economic status and anxiety. There was no significant relationship between stress and any of the variables.

Conclusion

Given the relatively high prevalence of anxiety, depression, and stress in MS patients as well as the significant relationship between their economic status and depression and anxiety, interventional measures are required to be taken to decrease their problems and to provide a favorable ground for their employment. Periodic examinations by psychologists / psychiatrists and treatment of patients with symptoms of stress, anxiety and depression are also essential.
Literature
1.
go back to reference Tan-Kristanto S, Kiropoulos LA. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychol Health Med. 2015;20(6):635–45.CrossRef Tan-Kristanto S, Kiropoulos LA. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychol Health Med. 2015;20(6):635–45.CrossRef
3.
go back to reference Saman-Nezhad B, Rezaee T, Bostani A, Najafi F, Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013;23(104):97–101. Saman-Nezhad B, Rezaee T, Bostani A, Najafi F, Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013;23(104):97–101.
5.
go back to reference Dehghani R, KazemiMoghaddam V. Potential causes of the in creased prevalence of multiple sclerosis in Iran: a review study. Pars J Med Sci. 2015;13(2):17–25. Dehghani R, KazemiMoghaddam V. Potential causes of the in creased prevalence of multiple sclerosis in Iran: a review study. Pars J Med Sci. 2015;13(2):17–25.
6.
go back to reference Farmani F, Taghavi H, Fatemi A, Safavi S. The efficacy of group reality therapy on reducing stress, anxiety and depression in patients with multiple sclerosis (MS). Int J Appl Behav Sci. 2015;2(4):33–8. Farmani F, Taghavi H, Fatemi A, Safavi S. The efficacy of group reality therapy on reducing stress, anxiety and depression in patients with multiple sclerosis (MS). Int J Appl Behav Sci. 2015;2(4):33–8.
7.
go back to reference Giordano A, Granella F, Lugaresi A, Martinelli V, Trojano M, Confalonieri P, et al. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci. 2011;307(1–2):86–91.CrossRef Giordano A, Granella F, Lugaresi A, Martinelli V, Trojano M, Confalonieri P, et al. Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci. 2011;307(1–2):86–91.CrossRef
8.
go back to reference Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP. Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol Assess. 1998;10(2):176.CrossRef Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP. Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol Assess. 1998;10(2):176.CrossRef
9.
go back to reference Giannakakis G, Pediaditis M, Manousos D, Kazantzaki E, Chiarugi F, Simos PG, et al. Stress and anxiety detection using facial cues from videos. Biomed Signal Process Contr. 2017;31:89–101.CrossRef Giannakakis G, Pediaditis M, Manousos D, Kazantzaki E, Chiarugi F, Simos PG, et al. Stress and anxiety detection using facial cues from videos. Biomed Signal Process Contr. 2017;31:89–101.CrossRef
10.
go back to reference Pham T, Jetté N, Bulloch AG, Burton JM, Wiebe S, Patten SB. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord. 2018;19:35–9.CrossRef Pham T, Jetté N, Bulloch AG, Burton JM, Wiebe S, Patten SB. The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord. 2018;19:35–9.CrossRef
11.
go back to reference Bhattacharjee S, Goldstone L, Ip Q, Warholak T. Depression treatment among adults with multiple sclerosis and depression in ambulatory care settings in the United States. Mult Scler Int. 2017;2017:3175358.PubMedPubMedCentral Bhattacharjee S, Goldstone L, Ip Q, Warholak T. Depression treatment among adults with multiple sclerosis and depression in ambulatory care settings in the United States. Mult Scler Int. 2017;2017:3175358.PubMedPubMedCentral
12.
go back to reference Boeschoten RE, Braamse AM, Beekman AT, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.CrossRef Boeschoten RE, Braamse AM, Beekman AT, Cuijpers P, van Oppen P, Dekker J, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci. 2017;372:331–41.CrossRef
13.
go back to reference Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS). BMC Psychiatry. 2012;12(1):6.CrossRef Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS). BMC Psychiatry. 2012;12(1):6.CrossRef
14.
go back to reference Sahebi A, Asghari MJ, Salari R. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Iranian Psychol. 2005;4(1):299–313. Sahebi A, Asghari MJ, Salari R. Validation of depression anxiety and stress scale (DASS-21) for an Iranian population. Iranian Psychol. 2005;4(1):299–313.
15.
go back to reference Miller RL, Pallant JF, Negri LM. Anxiety and stress in the postpartum: is there more to postnatal distress than depression? BMC Psychiatry. 2006;6(1):12.CrossRef Miller RL, Pallant JF, Negri LM. Anxiety and stress in the postpartum: is there more to postnatal distress than depression? BMC Psychiatry. 2006;6(1):12.CrossRef
16.
go back to reference Jafari H, Ebrahimi A, Aghaei A, Khatony A. The relationship between care burden and quality of life in caregivers of hemodialysis patients. BMC Nephrol. 2018;19(1):321.CrossRef Jafari H, Ebrahimi A, Aghaei A, Khatony A. The relationship between care burden and quality of life in caregivers of hemodialysis patients. BMC Nephrol. 2018;19(1):321.CrossRef
17.
go back to reference Dehghan A, Memarian R. Abundance of stress, anxiety and depression in multiple sclerosis patients. Alborz Univ Med J. 2013;2(2):82–8.CrossRef Dehghan A, Memarian R. Abundance of stress, anxiety and depression in multiple sclerosis patients. Alborz Univ Med J. 2013;2(2):82–8.CrossRef
18.
go back to reference Zarei M, Hasanzade MA, Sheykh S. Assessment of the prevalence of stress, anxiety and depression in multiple sclerosis patients conducted in Zahedan. J Stud Res Comm. 2014;19(3):13–21. Zarei M, Hasanzade MA, Sheykh S. Assessment of the prevalence of stress, anxiety and depression in multiple sclerosis patients conducted in Zahedan. J Stud Res Comm. 2014;19(3):13–21.
19.
go back to reference Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008;15(3):239–45.CrossRef Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008;15(3):239–45.CrossRef
20.
go back to reference Alsaadi T, El Hammasi K, Shahrour TM, Shakra M, Turkawi L, Mudhafar A, et al. Prevalence of depression and anxiety among patients with multiple sclerosis attending the MS clinic at sheikh Khalifa Medical City, UAE: Cross-Sectional Study. Mult Scler Int. 2015;2015:1–5.CrossRef Alsaadi T, El Hammasi K, Shahrour TM, Shakra M, Turkawi L, Mudhafar A, et al. Prevalence of depression and anxiety among patients with multiple sclerosis attending the MS clinic at sheikh Khalifa Medical City, UAE: Cross-Sectional Study. Mult Scler Int. 2015;2015:1–5.CrossRef
21.
go back to reference Esmaeili M. Evaluation of stress in patients with multiple sclerosis referred to MS Society of Iran. Aflak. 2013;4(6 & 7):20–5. Esmaeili M. Evaluation of stress in patients with multiple sclerosis referred to MS Society of Iran. Aflak. 2013;4(6 & 7):20–5.
22.
go back to reference Barzegar M, Badihian S, Mirmosayyeb O, Ashtari F, Jamadi M, Emami S, et al. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran. Mult Scler Relat Disord. 2018;22:161–5.CrossRef Barzegar M, Badihian S, Mirmosayyeb O, Ashtari F, Jamadi M, Emami S, et al. Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran. Mult Scler Relat Disord. 2018;22:161–5.CrossRef
23.
go back to reference Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, et al. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Mult Scler Relat Disord. 2018;20:9–15.CrossRef Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, et al. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Mult Scler Relat Disord. 2018;20:9–15.CrossRef
24.
go back to reference Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S. Multiple sclerosis and affective disorder: family history, sex, and HLA-DR antigens. Arch Neurol. 1988;45(12):1345–8.CrossRef Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S. Multiple sclerosis and affective disorder: family history, sex, and HLA-DR antigens. Arch Neurol. 1988;45(12):1345–8.CrossRef
25.
go back to reference Salehpoor G, Kafi S, Rezaei S, Hosseininezhad M, Salehi I. Depression and sub-clinical markers of multiple sclerosis. Arrmaghane Danesh. 2014;19(2):146–60. Salehpoor G, Kafi S, Rezaei S, Hosseininezhad M, Salehi I. Depression and sub-clinical markers of multiple sclerosis. Arrmaghane Danesh. 2014;19(2):146–60.
Metadata
Title
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study
Authors
Saba Karimi
Bahare Andayeshgar
Alireza Khatony
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2020
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-020-02579-z

Other articles of this Issue 1/2020

BMC Psychiatry 1/2020 Go to the issue